skip to primary navigationskip to content

Cambridge Science Festival 2011

Stem Cells ‘R’ Us!

s11 singleThe 2011 Cambridge Science Festival ran from the 14-27 March 2011 with the theme of 'Science for Life'.  The aim of the festival was to celebrate ways in which science, technology, engineering and mathematics change our lives. 

In order to deliver some key messages about stem cell research, staff from the Institute put on a fantastic exhibition. The expert team arranged games and activities and answered questions from visitors - 'Stem Cells ‘R’ Us' was in full flow for the exciting and busy event!

 

Activities for all agess11 differentiation poster 2011

Colouring sheets and The Stem Cell board game were fun for younger children, where they could see how different types of cells look, and race to win the game whilst learning about cellular differentiation. 

Learning how the different cells that make up the body have functional differences meant 8-13 year old visitors could be scientists and conduct an 'experiment’ with one of our experts. Our young scientists’ experiments were:

  • Under the Microscope:  seeing how stem cells can turn into any type of cell.
  • Drug Screen on Cells: a colour change experiment to illustrate that cells derived from stem cells can be used to assess whether new drugs work and whether they are toxic.
  • 'Easter Egg’ Cell Sorter: by using coloured, wrapped, small Easter eggs, the scientists could demonstrate that cells are different and we are able identify them and sort them in a lab based on these differences. 

 

s11 bis

 

Older children and adults were able to view a short film and see a slide show of cell images so they could learn how stem cells could be used in cell replacement therapies to treat human disease. There was plenty of opportunity to ask questions and learn more from our knowledgeable staff.

 

RSS Feed Latest news

Cancer treatment: study finds targeting nearby ‘normal’ cells could improve survival rates

Jan 16, 2020

Cancer of the immune system, called lymphoma or leukaemia, generally affects the entire body’s bone marrow and lymph nodes. Because these types of cancers are so widespread, surgery isn’t useful, so patients are usually treated with chemotherapy. Although these treatments have become significantly better in the past ten years, lymphoma and chronic leukaemia often come back months or years after treatment.

Single-cell analysis of the earliest cell fate decisions in development

Dec 11, 2019

Researchers at the Babraham Institute, EMBL’s European Bioinformatics Institute (EMBL-EBI), CRUK Cambridge Institute and the Wellcome – MRC Cambridge Stem Cell Institute have provided the first single-cell epigenomic analysis of gastrulation, a crucial process in early embryo development. The researchers analysed over 1,000 cells from mouse embryos to understand the epigenetic priming events preceding gastrulation and the cell fate decisions these establish. The findings, published on Wednesday 11th December in Nature, uncover fundamental knowledge about the processes that programme cell fate in the early embryo to generate all the organs and tissues of the body.

Affiliate group leader Florian Merkle named Robertson Stem Cell Investigator

Oct 23, 2019

The New York Stem Cell Foundation (NYSCF) announced the 2019 class of NYSCF – Robertson Investigators, welcoming six of the most talented stem cell researchers and neuroscientists into the NYSCF Investigator Program.

First cell map of developing human liver reveals how blood and immune system develop

Oct 09, 2019

In a world first, scientists have created the human developmental liver cell atlas that provides crucial insights into how the blood and immune systems develop in the foetus. It maps changes in the cellular landscape of the developing liver between the first and second trimesters of pregnancy, including how stem cells from the liver seed other tissues to support the high demand for oxygen needed for growth.

Diabetes drug reverses cell ageing and could stop multiple sclerosis

Oct 08, 2019

New research published in Cell Stem Cell suggests a common diabetes drug could hold the key to stopping disease progression in multiple sclerosis (MS). The new finding offers hope to people living with advanced forms of the condition, who currently have no treatment and often see disability as inevitable.

View all news

The Cambridge Stem Cell Institute is a world-leading centre for stem cell research.

Our mission: to transform human health through a deep understanding of stem cell biology.

 

Sign up to our newsletter to stay up-to-date with news and events from the Cambridge stem cell community.

Upcoming events

International Seminar - Francis Stewart (For scientists)

Feb 05, 2020

Jeffrey Cheah Biomedical Centre

Cambridge Science Festival - Open Science (For the public)

Mar 22, 2020

Jeffrey Cheah Biomedical Centre

Upcoming events